-
Mashup Score: 0ESOU 2022: SABR for Kidney Cancer. Still Experimental? - 2 year(s) ago
2022 EAU Section of Oncological Urology (ESOU), locally advanced and metastatic renal cancer, role of stereotactic ablative body radiotherapy (SABR) for kidney cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2ESOU 2022: Liquid Biomarkers in Advanced Kidney Cancer - 2 year(s) ago
2022 EAU Section of Oncological Urology (ESOU), locally advanced and metastatic renal cancer, circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), biomarkers of clear cell RCC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Liquid biomarkers in advanced #KidneyCancer. Presentation by @lewisjwau @royalmarsdenNHS. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/k2BGe91w2i @TurajlicLab @TheCrick @Uroweb https://t.co/TvnnlQs3Pn
-
-
Mashup Score: 0ESOU 2022: Future Directions of Systemic Treatment for mRCC: What Can We Expect in the Next 5 Years? - 2 year(s) ago
2022 EAU Section of Oncological Urology (ESOU), locally advanced and metastatic renal cancer, future directions of systemic treatment for metastatic renal cell carcinoma (RCC).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Future directions of systemic treatment for #mRCC: What can we expect in the next 5 years? Presentation by @AlbigesL @GustaveRoussy. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/8pHVNwptt1 @Uroweb https://t.co/7ZVt9WkS47
-
-
Mashup Score: 3ESOU 2022: State-of-the-Art Lecture – The Changing Face of Advanced Prostate Cancer and Implications for Evidenced Based Medicine - 2 year(s) ago
ESOU 2022 advanced prostate cancer aua guidelines, metastatic HSPC guidelines recommend genetic counseling and germline testing, newly diagnosed mCRPC guidelines, “precision based therapy” advanced prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
State-of-the-Art lecture – The changing face of advanced #ProstateCancer and implications for evidence-based medicine. Presentation by @michaelcookso18 @OUUrology. #ESOU22 written coverage by @WallisCJD @UofT. #ReadNow > https://t.co/NCif5IyGj7 @StephensonCC @Uroweb https://t.co/InNu01QFTd
-
-
Mashup Score: 1ESOU 2022: The Evolving Treatment Landscape and Clinical Trial Overview of Penile Squamous Cell Carcinoma - 2 year(s) ago
ESOU 2022 management of high-risk node positive penile cancer, penile squamous cell carcinoma, InPACT trial, locally advanced penile cancer, neoantigen expression in the neoadjuvant setting.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The evolving treatment landscape and clinical trial overview of penile squamous cell carcinoma. Presentation by @JadChahoud @MoffittNews. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/VEMX47VXaG @MoffittResearch @Uroweb https://t.co/rMBRJEOkq4
-
-
Mashup Score: 0
ESOU 2022 complications following robotic assisted partial nephrectomy, management robotic assisted partial nephrectomy, structured approach to assessing surgical complications, surgical complications partial nephrectomy
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Complications and management of robotic assisted partial nephrectomy. Presentation by @NNHarke. #ESOU22 written coverage by @WallisCJD @UofT. #ReadNow on UroToday > https://t.co/34iVonRiv8 @Uroweb https://t.co/BpSwBvHe1Z
-
-
Mashup Score: 1ESOU 2022: Functional Results Following Partial Nephrectomy; Acute Kidney Injury and Chronic Kidney Disease Consequences: A New Perspective - 2 year(s) ago
ESOU 2022 functional results following partial nephrectomy, ESU-ESOU-ERUS session, goal of nephron sparing surgery, short-term acute kidney injury (AKI) and longer-term chronic kidney disease (CKD).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Functional results following partial nephrectomy; Acute kidney injury and chronic #KidneyDisease consequences: A new perspective. Presentation by @minerviniandre @AOUCareggi. #ESOU22 written coverage by @WallisCJD @UofT on UroToday > https://t.co/wn8QSbRGWB @Uroweb https://t.co/DIUgeUeTjo
-
-
Mashup Score: 2ESOU 2022: Neoadjuvant Treatments before Radical Prostatectomy for High-Risk Prostate Cancer: Developments and Challenges - 2 year(s) ago
ESOU 2022 neoadjuvant treatments before radical prostatectomy for high-risk prostate cancer, localized high-risk prostate cancer, 15-year prostate cancer-specific mortality rates.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Neoadjuvant treatments before radical prostatectomy for high-risk #ProstateCancer: Developments and challenges. Presented by Mary-Ellen Taplin, MD @DanaFarber. #ESOU22 written coverage by @zklaassen_md @GACancerCenter. #ReadNow > https://t.co/C0pJh6h7iy @Uroweb https://t.co/SFhhW19Lpr
-
-
Mashup Score: 3
ESOU 2022 choosing transperitoneal or retroperitoneal approaches for robotic partial nephrectomy, ESU-ESOU-ERUS session, minimally invasive surgical approaches, retroperitoneal robotic partial nephrectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Robotic transperitoneal and retroperitoneal approach: When and how? Presentation by @NNHarke. #ESOU22 written coverage by @WallisCJD @UofT on UroToday > https://t.co/BuxALmk22M @Uroweb https://t.co/LXAowx9GNo
-
-
Mashup Score: 2
ESOU 2022 role of robotic partial nephrectomy for T1 and T1 renal tumors, ESU-ESOU-ERUS session, localized renal masses, treatment of renal cell carcinoma (RCC), partial nephrectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Indication and results of robotic partial nephrectomy for T1/T2 tumors. Presentation by @minerviniandre @AOUCareggi. #ESOU22 written coverage by @WallisCJD @UofT. #ReadNow on UroToday > https://t.co/uIimwNsUpL @Uroweb https://t.co/kdK5WRudmA
-
Stereotactic ablative body radiotherapy for #KidneyCancer. Still experimental? Presentation by @_ShankarSiva @PeterMacCC. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/rWVj56NJ3g @Uroweb https://t.co/KmPseImdAW